Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Pexidartinib often causes liver issues and fatigue, especially in women.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Double pulse dose terbinafine effectively treats kerion type of tinea capitis.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Metformin helps regenerate hair follicles in lab conditions.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Bimatoprost effectively improves eyelashes in chemotherapy patients.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.